Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy
'Diversified supply chain is a fundamental need', said Jain
New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland
As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country
Players say low prescription, double-digit price erosion are key reasons
Drug firm Dr Reddy's Laboratories on Wednesday said it has entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its US and Canada territory rights
A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors
The approval of samples, licensing, and final production will take around two months and the vaccine would be available in India for sale also in two months, says CMD Sushil Suri
Leading drug makers have decided to collaborate for clinical trial of the investigational oral antiviral drug Molnupiravir
Firms work to secure raw material locally as imports remain a challenge
Pharma exports from India witnessed over 18 per cent growth to USD 24.44 billion during the last financial year against USD 20.58 billion in FY20
Here's a selection of Business Standard opinion pieces for the day
Disruption to supplies from China due to the Covid-19 pandemic was also a major factor
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities
Exports grew 16.22 per cent year-on-year to $6.21 billion in the first week of January, mainly driven by healthy growth in pharmaceuticals, and engineering sectors, reflecting signs of revival
To the media, Somani may be a man of few words but among peers he's known for quick responses
Created 7 billionaires in 2020; now 17 super-rich promoters in the sector with combined wealth of Rs 4.35 trillion
Approval to Covaxin raises many questions
MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market
India's proposed WTO waiver faces stiff opposition from the US and EU